Accountable care organizations (ACOs) have been laying the groundwork for the requirements for the Medicare Access and CHIP Reauthorization Act (MACRA), which will give physicians participating in ACOs an advantage during the implementation of the new Medicare payment system, said Katherine Schneider, MD, president of the Delaware Valley ACO.
Accountable care organizations (ACOs) have been laying the groundwork for the requirements for the Medicare Access and CHIP Reauthorization Act (MACRA), which will give physicians participating in ACOs an advantage during the implementation of the new Medicare payment system, said Katherine Schneider, MD, president of the Delaware Valley ACO.
Transcript
How can ACOs help physicians prepare for the implementation of the MACRA final rule?
ACOs are really an important part of the preparation for the change from volume to value, in general, and MACRA is just one piece of that from the point of view of Medicare’s direction. For those of us who have been in ACOs that have been operating for a couple of years, I think we have been laying the groundwork for the requirements of MACRA really effectively, and I can give you an example from the Delaware Valley ACO, where this year we have 650 primary care physicians, we’re in our third year of operation in 2016, and many of the requirements under MIPS [Merit-based Incentive Payment System] and MACRA, we have been prepping our physicians and practices for because they are aligned with the tools you need to have in your tool belt to succeed under value-based care.
So things like, not just having an EMR [electronic medical record], but really optimizing the use of the EMR; where you put your data, really being able to extract data; the patient-centered medical home type of requirements around access, care coordination, proactive panel management and population health management. Those are all the kinds of tools that practices will need to be successful under MACRA, whether or not they’re actually in an ACO in the future. So that’s part 2—clearly being in an ACO or some form of an organized alternative payment model provides advantages under MIPS or MACRA that practices would not be able to achieve on their own, particularly the smaller practices.
So not only are we helping them to prepare in terms of their own processes, but being in the ACO gives some benefits: they don’t have to do their own reporting, because they’re actually already reporting through the ACO, so they don’t have to double reporting, and they receive some extra credit in certain categories for the work that they’re doing through the ACO.
So we want to message carefully to our practices that it’s not just, “Oh, you’re in an ACO, you don’t have to worry about this.” The message is, “You’re in an ACO, you’re already doing this work, and CMS wants to give you credit for the work that you are doing under the ACO model by providing some advantages under MACRA.”
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More